Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioScience Ventures Group

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 5
Lead investments 1
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
  • Project Management
  • Nanotechnology
Summary

The main department of described VC is located in the Munich. The company was established in Europe in Germany.

The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2007.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the BioScience Ventures Group, startups are often financed by Limburg Ventures. The meaningful sponsors for the fund in investment in the same round are NV Industriebank LIOF, Limburg Ventures, High-Tech Gru00fcnderfonds. In the next rounds fund is usually obtained by The Austrian Research Promotion Agency (FFG).

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Austria. Among the most successful fund investment fields, there are Biotechnology, Biopharma. Among the most popular portfolio startups of the fund, we may highlight APEPTICO Forschung und Entwicklung, ugichem.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioScience Ventures Group:
Typical Co-investors
BioScience Ventures Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioScience Ventures Group:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
7-Eleven Irving, Texas, United States
Atlas Holdings Connecticut, Greenwich, United States
CoreNetwork Fund Ohio, Toledo, United States
Dash Fund -
Doing Now Beijing, Beijing, China
Dutch Technology Foundation STW Netherlands, Utrecht, Utrecht
GRIDS Capital Brazil, São Paulo, São Paulo
GT-MAX -
Huoerguosi Jiubang Xinxi Jishu Youxian Gongsi -
Joyo Industrial Research Institute Ibaraki Prefecture, Japan, Mito
Modea Blacksburg, United States, Virginia
NBP Asia Investments -
Paladin Labs Canada, Montreal, Quebec
Perspective Capital Management -
Rogers Communications Canada, Ontario, Toronto
SP Investment Associates (SPIA) -
Straus Partners Denmark, Holstebro, Midtjylland
Woofoo Capital China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MagnaMedics

Biotechnology
Nanotechnology
Project Management
01 Feb 2011 Limburg

Biopharma
Biotechnology
Therapeutics
$4M05 Aug 2010 Vienna, Austria

Diaferon

Biotechnology
$927K09 Jul 2007 Munich, Bavaria, Germany

Biotechnology
Medical
Therapeutics
$1M17 May 2007 Innsbruck, Tyrol, Austria

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioScience Ventures Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 1M
Peak activity year 2007
Lead investments 1
Group Appearance index 0.40

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

MagnaMedics

Biotechnology
Nanotechnology
Project Management
01 Feb 2011 Limburg

Biopharma
Biotechnology
Therapeutics
$4M05 Aug 2010 Vienna, Austria

Diaferon

Biotechnology
$927K09 Jul 2007 Munich, Bavaria, Germany

Biotechnology
Medical
Therapeutics
$1M17 May 2007 Innsbruck, Tyrol, Austria
Crunchbase icon

Content report

The following text will be sent to our editors: